Atlas Trials

Sickle Cell Disease (SCD)

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Sickle Cell Disease (SCD)

RecordFirmDate
Risk Factors, Costs, and Impacts of ED Boarding (NCT07532564)University of Maryland, Baltimore2022-01-01
An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients (NCT04662931)Novartis Pharmaceuticals2021-07-14
Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of Adults and Parents of Children Living with Sickle- Cell Disease in France (NCT04413539)Argo Sante2020-06-02
Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease (NCT04053764)Novartis Pharmaceuticals2019-12-10
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (NCT03814746)Novartis Pharmaceuticals2019-07-26
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients (NCT03474965)Novartis Pharmaceuticals2018-10-01
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging (NCT03478917)National Heart, Lung, and Blood Institute (NHLBI)2018-02-27
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) (NCT03264989)Novartis Pharmaceuticals2017-12-19

Track Sickle Cell Disease (SCD) automatically

Every clearance here is in the API, with alerts when new ones post.